Says COVID revenue guidance assumes no government contract revenue. Says Labs business growth expected in mid-single digits in FY25. Sees FY25 gross tariff impacts of $20M-$25M to be fully mitigated through cost actions. Says achieved $100M annualized cost-savings initiatives. Guidance taken from Q2 earnings conference call presentation slides.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL:
